Recent understanding of the molecular mechanisms for the efficacy and resistance of EGF receptor-specific tyrosine kinase inhibitors in non-small cell lung cancer.
about
Suppression of cancer relapse and metastasis by inhibiting cancer stemnessCritical role of Spns2, a sphingosine-1-phosphate transporter, in lung cancer cell survival and migration.Response of the insulin-like growth factor (IGF) system to IGF-IR inhibition and androgen deprivation in a neoadjuvant prostate cancer trial: effects of obesity and androgen deprivation.Transcriptional changes associated with resistance to inhibitors of epidermal growth factor receptor revealed using metaanalysis.Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs.Review of the treatment of non-small cell lung cancer with gefitinib.Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivoLow-frequency KRAS mutations are prevalent in lung adenocarcinomasReversion of erlotinib-acquired resistance twice by chemotherapy: a case report.Histone deacetylase inhibitors: a patent review (2009 - 2011).Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology.Advances towards the design and development of personalized non-small-cell lung cancer drug therapy.Molecular basis of drug resistance: epidermal growth factor receptor tyrosine kinase inhibitors and anaplastic lymphoma kinase inhibitors.Afatinib for the treatment of advanced non-small-cell lung cancer.The critical role of EGF-β-catenin signaling in the epithelial-mesenchymal transition in human glioblastoma.Cyclic versus hemi-bastadins. pleiotropic anti-cancer effects: from apoptosis to anti-angiogenic and anti-migratory effects.Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell lung cancer: a novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin.Griffipavixanthone from Garcinia oblongifolia champ induces cell apoptosis in human non-small-cell lung cancer H520 cells in vitro.BMP4 Upregulation Is Associated with Acquired Drug Resistance and Fatty Acid Metabolism in EGFR-Mutant Non-Small-Cell Lung Cancer Cells
P2860
Q35090120-985249A4-A359-4366-9BEB-6B67BFE9ED8AQ35351053-B606467B-0D60-44D4-9C8E-963A445393A7Q35603263-4E86FDB4-E256-48C0-B9AB-B87B3BCF32EEQ35604127-83400112-21D2-402D-85AE-AE25BD6BCB47Q35948915-48DFA1E4-89E6-467E-990F-EC641D6E565DQ36461805-142E5684-1F2A-4360-B8AB-9EA6055CCE01Q37107787-26E95A9D-0DAA-42A9-B000-5A09A9C98FDDQ37375834-5A59626E-F53B-401C-9783-CBA9896986F4Q37591461-50CF2A76-9045-4D3C-889B-1A2FAA1BAB22Q38055210-115F3B71-CD77-4049-A01D-F3E4A5514BF4Q38096410-118DC657-2785-44EC-8580-D99B3F260947Q38148583-F1EF8B9A-837F-447D-900C-D687859AD999Q38172148-5F92E75F-D694-456B-9CCF-BBC99348C673Q38197278-549E984C-9C17-43C4-897E-1D367A3FB867Q38700305-ED852F9A-5636-49F9-997B-1AB4F9AD8E26Q39177393-872CE4D6-F838-47DB-A55F-38CAC1817152Q41878464-3B182DD6-32BE-4B8E-86B6-5068C732A858Q46939852-56166F99-6151-42CD-9491-CEFBEFBD9302Q58800444-D3762705-7477-45D7-BA0B-456AE479AAC3
P2860
Recent understanding of the molecular mechanisms for the efficacy and resistance of EGF receptor-specific tyrosine kinase inhibitors in non-small cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Recent understanding of the mo ...... in non-small cell lung cancer.
@en
type
label
Recent understanding of the mo ...... in non-small cell lung cancer.
@en
prefLabel
Recent understanding of the mo ...... in non-small cell lung cancer.
@en
P2860
P1476
Recent understanding of the mo ...... in non-small cell lung cancer
@en
P2093
Asuka Nakata
P2860
P304
P356
10.1517/14728222.2012.697155
P407
P50
P577
2012-07-05T00:00:00Z